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Introduction {#sec0005}
============

*Staphylococcus* spp. play an important role in the etiology of intramammary infections of dairy cattle. *Staphylococcus aureus* stands out among the prevalent etiologic agents in this type of infection due to its ability to produce a wide array of virulence factors that contribute to the bacterial invasion.[@bib0205] Of them, the production of slime, an extracellular mucopolysaccharide, appears to play a crucial role in the adhesion and colonization of the microorganism on the mammary glandular epithelium; this not only favors biofilm formation and their extracellular persistence but also ensures success in their installation and maintenance in the host tissues.[@bib0210] Slime is composed of a high-molecular-weight polysaccharide intercellular adhesin. Its production is mediated by the intercellular adhesion operon (ica) formed by the genes *ica*A, *ica*B, *ica*C, and *ica*D and a regulator gene, *icaR*, which encodes the ICAA, ICAB, ICAC, and ICAD proteins.[@bib0215]

Furthermore, *ica*-independent mechanisms possibly play an essential role in bacterial biofilm formation. For example, the function of *bap*, which encodes for the surface protein Bap, is to assist in intercellular adhesion and biofilm formation. This gene has been primarily studied in isolates from bovine mastitis.[@bib0220]

The repression of *agr* quorum-sensing system is necessary for biofilm formation. Its reactivation in established biofilms through auto inducing peptides (AIPs) addition or glucose depletion triggers biofilm detachment.[@bib0225] The *agr* system includes AgrD, the signaling octapeptide produced in high cell density; AgrB, a transmembrane protein responsible for secretion, export, and processing of active AgrD; and AgrC, a membrane receptor that triggers AgrA phosphorylation mechanism when bound to AgrD. The phosphorylated AgrA positively regulates the production of the effector molecule RNA III.[@bib0230] *S. aureus* can be classified into four polymorphic Agr types (AgrI, AgrII, AgrIII, and AgrIV) based on the specificity of AIP to the signal receptor AgrC.[@bib0235]

Moreover, biofilm production in *S. aureus* from mastitis can be associated with antimicrobial resistance.[@bib0240] The mechanisms responsible for this resistance include the physical and chemical diffusion barrier formed by the exopolysaccharide matrix, which hinders antimicrobial penetration, the existence of microenvironments that antagonize the antibiotic action, the activation of stress responses that cause changes in bacterial physiology, and the stable and slower growth of these microorganisms due to nutrient limitation and the absence of antimicrobial targets.[@bib0210]

Antimicrobials such as beta-lactams are preferred for the treatment of staphylococcal infections. However, production of beta-lactamase enzymes, coded by *blaZ* that hydrolyzes the beta-lactamic ring, and production of low-affinity penicillin binding protein (PBP2a), coded by *mec*A, may lead to antimicrobial resistance.[@bib0245]

This study aimed to detect the phenotypic expression of biofilm and the presence of structural and regulatory genes involved in the production of this virulence factor. In addition, the stages of biofilm synthesis along the growth curve were evaluated by scanning electron microscopy (SEM), and pheno-genotypic resistance to beta-lactamic and its possible relation to biofilm production were evaluated.

Materials and methods {#sec0010}
=====================

Sampling and pheno-genotypic and proteomic identification {#sec0015}
---------------------------------------------------------

Three dairy cattle farms located in an important milk production region of Rio de Janeiro, Brazil, were selected owing to the high prevalence of subclinical mastitis on the farms, identified through the California mastitis test and somatic cell count. In total, 120 milk samples were collected in October and November 2012. Fifty nine *Staphylococcus* spp. were isolated, of which 41 were *S. aureus* strains.

After phenotypic identification, all 41 strains were submitted to polymerase chain reaction (PCR) for 16S rRNA to confirm the *Staphylococcus* spp.[@bib0250] PCR for *coa*,[@bib0255] *nuc*,[@bib0260] and 23S rDNA[@bib0265] genes were performed to characterize *S. aureus*. The ATCC 29213 *S. aureus* was used as quality control. Furthermore, all isolates were evaluated by the matrix-assisted laser desorption ionization-time of flight mass spectrometry, as described by Motta et al.,[@bib0270] considering the accepted values for matches ≥2.

The *S. aureus* isolates were subjected to disk diffusion tests using amoxicillin (10 μg), ampicillin (10 μg), azithromycin (15 μg), ciprofloxacin (5 μg), chloramphenicol (30 μg), cefepime (30 μg), enrofloxacin (5 mcg), erythromycin (15 μg), streptomycin (10 μg), moxifloxacin (5 μg), neomycin (30 mcg), novobiocin (5 mcg), cotrimoxazole (25 μg), and tetracycline (30 μg) disks. After overnight incubation at 35 °C, followed by inhibition zone measurement, the results were interpreted according to Clinical and Laboratory Standards Institute (CLSI) standards.[@bib0275], [@bib0280], [@bib0285] These isolates were subjected to DNA extraction and amplification of *hl*A and *hlB*,[@bib0290] *fbnA* and *fbnB*,[@bib0295] and *cap5* and *cap8*,[@bib0295] according to the protocol described by Marques et al.[@bib0300] and Tito et al.[@bib0305] To study the biofilm production, 20 *S. aureus* strains were selected considering their antibiotic resistance profiles and the presence of virulence genes.

Qualitative and quantitative biofilm assay {#sec0020}
------------------------------------------

Biofilm production was measured using qualitative and quantitative assays, described by Marques et al.[@bib0300] All the 20 *S. aureus* isolates were transferred to sheep blood agar for 24 h at 35 °C. The grown colonies were inoculated into tryptic soy broth (TSB) containing 0.24% glucose to stimulate slime production for 24 h at 35 °C. The bacterial cultures were adjusted to a 0.5 McFarland scale and diluted 1:10 in TSB with the addition of 0.24% glucose. Aliquots of this suspension (200 μL) were inoculated into sterile polystyrene 96-wellmicroplates for 24 h at 35 °C without agitation. After discarding this material, the wells were washed twice with 200 μL sterile saline, oven dried at 65 °C for 1 h, and stained with 200 μL safranin 1% for 15 min. Subsequently, the wells were washed three times with distilled water and dried at room temperature. The absorbance was determined at 490 nm in an ELISA reader (BIO RAD MODEL 680). Uninoculated wells containing TSB broth with 0.24% glucose were used as controls. The tests were performed in triplicate. The strains were classified according to the following OD values: strong ≥0.3, moderate ≥0.2 and \<0.3, weak ≥0.1 and \<0.2, and negative \<0.1.[@bib0300]

Biofilm gene and Agr types {#sec0025}
--------------------------

All isolates were subjected to DNA extraction and amplification of *ica*A and *ica*D,[@bib0310] *bap*,[@bib0240] and *agr RNAIII*,[@bib0315] according to the protocol described by Marques et al.[@bib0300] and Tito et al.[@bib0305] ([Table 1](#tbl0005){ref-type="table"}).

The *agr* system groups were classified based on the hypervariable domain of the *agr* locus, according to Shopsin et al.[@bib0235] A forward primer, *pan-agr*, corresponding to the conserved sequences of *agrB*, was used in all the reactions. Furthermore, four reverse primers were used, each specific for the amplification of a single group of *agr*, based on the *agr* locus polymorphism. Duplex PCR was performed to classify the groups based on the following products: Agr I (440 bp) and Agr II (572 bp) and Agr III (406 bp) and Agr IV (588 bp) ([Table 1](#tbl0005){ref-type="table"}). PCR products were separated by electrophoresis on 1% agarose gels using SYBR *Green* (Invitrogen^®^) diluted dye (1:100). The amplicons were visualized and documented using the image capturing system L-PIX EX (Loccus Biotecnologia^®^).

Growth curve estimation {#sec0030}
-----------------------

A 1-mL aliquot of bacterial culture \[10^6^ CFU (colony forming unit)/mL\] was diluted ten-fold in a simple broth (0.4% meat extract; 1% peptone, and 0.5% NaCl). Bacterial growth was evaluated considering the following intervals: 0, 2, 4, 6, 8, 10, 12, 24, 30, 36, and 48 h. After incubation at 35 °C for 18 h, the viable cells were counted in plate count agar and expressed as CFU per milliliter. The experiment was performed in triplicate. Further, the biofilm production of N--341 was evaluated considering the intervals determined in the bacterial growth curve.

Preparation of biofilm samples for SEM {#sec0035}
--------------------------------------

Bacterial growth was observed on Petri dishes containing glass cover slips for biofilm adhesion. The isolates N--354, N--365, and N--341 were cultivated in TSA with 0.24% glucose overnight, adjusted to the 0.5 McFarland scale, and diluted 1:10 in TSA with 0.24% of glucose. The aliquots (2 mL each) were placed in each Petri dish containing three glass coverslips and were statically incubated at 35 °C for 4, 8, 12, and 24 h. After incubation, the Petri dish was washed three times with saline (0.85% NaCl) to remove all planktonic cells. The adherent cells were fixed with 5% glutaraldehyde for 5 h. After fixation, the plate was washed three times with 0.1 M sodium cacodylate buffer. For SEM, *S. aureus* cells were fixed for 30 min at room temperature with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) and post-fixed for 30 min at room temperature with 1% OsO~4~ solution containing 2.5 mM CaCl~2~ in the same buffer. The cells were dehydrated in an ascending acetone series and dried using the critical point method with CO~2~ (CPD 030, Balzers, Switzerland). Subsequently, the samples were mounted on aluminum stubs, coated with a 20-nm gold layer, and examined under a scanning electron microscope (Jeol JSM6390LV) at the Rudolf Barth Electron Microscopy Platform of Institute Oswaldo Cruz.

Evaluation of pheno-genotypic resistance to beta-lactamic {#sec0040}
---------------------------------------------------------

All the 20 *S. aureus* isolates were subjected to disk diffusion tests using cefoxitin (30 μg), oxacillin (10 μg), penicillin (10 UI), and amoxicillin + clavulanic acid (30 μg) disks. In addition, the "edge zone" test was used to evaluate the production of beta-lactamases. After overnight incubation at 35 °C, followed by inhibition zone measurement,[@bib0280], [@bib0285] the results were evaluated as per the interpretation criteria following the CLSI standards.[@bib0275] PCR was performed for *mec*A using primers designed by Murakami et al.[@bib0320] and Melo et al.[@bib0325] and for *bla*Z according to Rosato et al.[@bib0330] ([Table 1](#tbl0005){ref-type="table"}).

Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) tests were performed according to CLSI[@bib0275] for the isolates N--354, N--365, and N--341 using different concentrations ranging from 0.25, 0.5, 1.0, 2.0, 4.0, 8.0, 16, 32, 64, 128, 256 to 512 μg/mL in MH broth. For MBC determination, cefoxitin cultures with concentrations above the MIC were inoculated in AMH.[@bib0335]

Results and discussion {#sec0045}
======================

The *S. aureus* isolates, which were identified by phenol-genotypic and proteomic techniques, were tested for sensitivity to certain antimicrobial agents and the presence of virulence genes for the fibronectin, hemolysin, and capsule. These results were used to create profiles highlighting the more distinct characteristics of the strains and representatives were collected. Therefore, 20 *S. aureus* strains were selected considering their antibiotic resistance profiles and the presence of virulence genes ([Table 2](#tbl0010){ref-type="table"}).

All the 20 *S. aureus* strains were biofilm producers, classified as strong (55% = 11/20), moderate (30% = 6/20), and weak (15% = 3/20) producers. It is important to detect *Staphylococcus* spp. Isolates that produce biofilms because this virulence factor guarantees the installation and maintenance of the bacteria in the glandular breast tissue.[@bib0340] Moreover, the polysaccharide mucus of biofilms facilitates bacterial adhesion to biomaterials, which is not removable despite repeated washings; therefore, its production is associated with infections caused by milking machines.[@bib0345]*ica*A and *ica*D were detected in 17 (85%) and 19 (95%) isolates, respectively. Sixteen isolates tested positive for both the genes and only one (5%) tested positive for *bap* ([Table 3](#tbl0015){ref-type="table"}). The low incidence of *bap* indicates that the *ica*-dependent mechanism, slime producer, may be primarily responsible for the adhesion and biofilm formation in the strains, as reported by Vautor et al.[@bib0350] All the biofilm-producing strains presented either *icaA* or *icaD* or both. However, no relation was observed between the biofilm formation intensity and number of amplified *icaA* and *icaD*. Arciola et al.[@bib0355] did not observe any relationship between slime production and the presence of these genes, suggesting that it could be a consequence of the experimental conditions such as lower sugar concentration in the agar or shorter incubation period.

All the *S. aureus* isolates tested positive for *agr RNAIII*. Although RNAIII is not essential for *S. aureus* growth *in vitro*, it modulates the expression of genes involved in its pathogenesis.[@bib0360] In fact, the roles of *agr* and quorum sensing in biofilm formation remain elusive. The Agr type II group was prevalent in 14 isolates, but the remaining six isolates could not be typed by the adopted technique. Moreover, Melchior et al.[@bib0365] found a high prevalence of Agr type II in 81% *S. aureus* isolates from bovine mastitis in the Netherlands, whereas 9% were Agr type I group. In addition, they suggested Agr type II strains are better adapted to the dairy environment than Agr type I strains. A study by Fabre-Klein et al.[@bib0370] suggested that *S. aureus* strains increase biofilm production to adapt to the milk-filled environment of the udder. The absence of the *agr* system function facilitates the initial adhesion of staphylococci to surfaces, presumably due to the positive expression of adhesion molecules and negative expression of biofilm formation factors, which are released in the late stationary phase.[@bib0375]

The *S. aureus* isolate N--341was tested positive for *ica*A, *ica*D, and *agr* and presented a strong biofilm production in the assays; therefore, it was selected for the growth curve estimation. The biofilm production of N--341 in microplates was evaluated according to the time intervals of the growth curve assay considering the following phases: lag until 4 h, exponential reaching the plateau at 12 h, and death from 24 h. The biofilm production reached its peak at 12 h (OD = 0.596). At SEM, this isolate displayed a meshwork-like structure associated with the surface and with various gaps at 8 h of growth; this was not apparent at 4 h. At 12 h of growth, these gaps decreased in size and the cell layer became thicker, indicating the possible establishment of the biofilm. Within 24 h, the surface was filled with dense cell clusters ([Fig. 1](#fig0005){ref-type="fig"}), probably indicating the next stage of biofilm formation. Using this model, it was possible to detect gradual changes in the biofilm complexity during the different stages of *S. aureus* growth. Therefore, our model used for biofilm formation and the procedure for cultivation of strains in TSA with 0.24% glucose in microplates and glass cover slips for 24 h at 35 °C without agitation can be satisfactorily used.

Recently, Savage et al.[@bib0380] reported that biofilm mode of growth increases horizontal transfer of plasmid-borne antibiotic resistance determinants by conjugation in *S. aureus.* In addition, the biofilm can act as a barrier preventing the adsorption/penetration of antimicrobials, and the matrix promotes their dilution to subinhibitory concentrations. Moreover, the difference in bacterial physiology presented in the biofilm can influence the efficacy of antibiotics.[@bib0385] In this study, all isolates were sensitive to oxacillin and cefoxitin in the disk diffusion test, supporting the results of previous studies stating that the prevalence of oxacillin resistance in *S*. *aureus* isolates from bovine mastitis is low.[@bib0390], [@bib0395] In the diffusion disk test, 15 isolates showed a sensitivity zone \>29 mm, but five were resistant to penicillin. The CLSI indicates that staphylococci producing beta-lactamase may be phenotypically sensitive; therefore, before reporting their sensitivity, it is recommended that these isolates should be tested for beta-lactamase production. The recommended phenotypic test for the production of beta-lactamase in *S. aureus*, *i.e.*, the edge zone test, interprets the growth on the border of the inhibition zone. This test is considered more sensitive for *S. aureus* than the nitrocefin test.[@bib0280] In the edge zone test, 100% (15/15) of the sensitive isolates were positive and were reported as penicillin resistant. A previous study has reported high resistance to penicillin in coagulase-positive staphylococci isolated from bovine mastitis cases.[@bib0390] However, this antibiotic is rarely considered a treatment option for mastitis, although some producers still insist on using it due to its low cost.

Furthermore, the susceptibility to amoxicillin associated with the beta-lactamase inhibitor was 100%, suggesting that the mechanism of beta-lactamase production may lead to penicillin resistance. Among the isolates considered resistant to penicillin, 70% (14/20) possessed *bla*Z and were tested negative for *mec*A using two different primers. Of the six isolates tested negative for both *bla*Z and *mec*A, five displayed moderate or strong biofilm production.

The MIC and MBC for cefoxitin were analyzed for the isolates N--354, N--365, and N--341. The stronger biofilm producer N--341 presented the highest MIC and MBC (1and 64 μg/mL, respectively), followed by the moderate producer N--365 (\<0.25and 4 μg/mL, respectively). The weaker biofilm producer N--354 presented the lowest MIC and MBC (\<0.25 μg/mL for both). Since N--341 was negative for *bla*Z and *mec*A, the high cefoxitin MBC value may be associated with biofilm protection. Wells et al.[@bib0400] discussed that there is no universal acceptable methodology for evaluating antimicrobial resistance and biofilm production. Based on this, it appears that exopolysaccharides (EPS) secreted by the bacteria act as a barrier that may play a role in this resistance, preventing the adsorption and penetration of antimicrobials. Moreover, the EPS matrix could neutralize or bind these compounds, promoting their dilution to subinhibitory concentrations before they reach the cells. In addition, biofilms are composed of both dormant and active cell subpopulations. This difference in the bacterial physiology can influence the efficacy of antibiotics.[@bib0385]

In conclusion, all the 20 isolates were biofilm producers and mostly presented *ica*A and *ica*D; only the N--341 strain was positive for *bap*. *agr RNAIII* was detected in all the isolates, and Agr type II showed a significant prevalence. The N--341 strain showed gradual changes in the complexity of the biofilm along the phases of growth curve in SEM, reaching the peak at the stationary phase. Moreover, the detected penicillin resistance was related to the production of beta-lactamase due to the absence of *mec*A and sensitivity to amoxicillin + clavulanic acid in all the isolates. Finally, because N--341 was negative for the tested resistance genes, the cefoxitin MBC of 64 μg/mL may be associated with biofilm protection since this strain is a strong producer of this virulence factor.

Taken together, these data suggest that a greater understanding of biofilm formation may add to our knowledge on bacterial resistance *in vivo*. Thus, studies that uncover colonization factors in biofilm formation are important and will form the basis for the development of treatments for bacterial resistance in biofilms.
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![Scanning electron micrographs of strain N--341 showing morphological changes associated with growth. Meshwork-like structures associated to the surface with various gaps were observed at 8 h of growth, these structures were not apparent at 4 h. At 12 h of growth, the gaps decreased in size and the cell layer became denser and at 24 h the surface was filled with dense cell clusters.](gr1){#fig0005}

###### 

Primers and amplification conditions for the detection of resistance, biofilm genes, and *agr* genes.

Table 1

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene (fragment)         Primer Sequence (5′--3′)              Cycles                                                                      Reference
  ----------------------- ------------------------------------- --------------------------------------------------------------------------- ------------------------------
  *ica*A (1315 bp)        CCT AAC TAA CGA AAG GTA G\            (92 °C 45 s, 49 °C 45 s, 72 °C 1 min) × 30 and 72 °C 7 min                  Vasudevan P et al.[@bib0310]
                          AAG ATA TAG CGA TAA GTG C                                                                                         

  *ica*D (381 bp)         AAA CGT AAG AGA GGT GG\               (92 °C 45 s, 49 °C 45 s, 72 °C 1 min) × 30 and 72 °C 7 min                  Vasudevan P et al.[@bib0310]
                          GGC AAT ATG ATC AAG ATA C                                                                                         

  *bap* (971 bp)          CCC TAT ATC GAA GGT GTA GAA TTG\      94 °C 2 min (94 °C 30 s, 55 °C 30 s, 72 °C 75 s) × 40 and 72 °C 5 min       Cucarella C et al.[@bib0240]
                          GCT GTT GAA GTT AAT ACT GTA CCT GC                                                                                

  *agr RNAIII* (200 bp)   CAT AGC ACT GAG TCC AAG GA\           94 °C 3 min (94 °C 1 min, 55 °C 1 min, 72 °C 1 min) × 30 and 72 °C 5 min    Reinoso EB[@bib0315]
                          CAA TCG GTG ACT TAG TAA AAT G                                                                                     

  *agr I* (440 bp)        ATG CAC ATG GTG CAC ATG C\            (94 °C 1 min, 55 °C 1 min, 72 °C 1 min) × 25                                Shopsin B et al.[@bib0235]
                          GTC ACA AGT ACT ATA AGC TGC GAT                                                                                   

  *agr II* (572 bp)       ATG CAC ATG GTG CAC ATG C\            (94 °C 1 min, 55 °C 1 min, 72 °C 1 min) × 25                                Shopsin B et al.[@bib0235]
                          GTA TTA CTA ATT GAA AAG TGC CAT AGC                                                                               

  *agr III* (406 bp)      ATGCACATGGTGCACATGC\                  (94 °C 1 min, 55 °C 1 min, 72 °C 1 min) × 25                                Shopsin B et al.[@bib0235]
                          CTGTTGAAAAAGTCAACTAAAAGCTC                                                                                        

  *agr IV* (588 bp)       ATGCACATGGTGCACATGC\                  (94 °C 1 min, 55 °C 1 min, 72 °C 1 min) × 25                                Shopsin B et al.[@bib0235]
                          CGATAATGCCGTAATACCCG                                                                                              

  *mec*A (533 bp)         AAA ATC GAT GGT AAA GGT TGG C\        94 °C 4 min (94 °C 30 s, 53 °C 30 s, 72 °C 1 min) × 30 and 72 °C 4 min      Murakami KW et al.[@bib0320]
                          AGT TCT GCA GTA CCG GAT TTG C                                                                                     

  *mecA* (574 bp)         ACG TTA CAA GAT ATG AAG\              95 °C 5 min (94 °C 1 min, 55 °C 1 min, 72 °C 1 min) × 30 and 72 °C 10 min   Melo DA et al.[@bib0325]
                          ACA TTA ATA GCC ATC ATC                                                                                           

  *bla*Z (861 bp)         TAC AAC TGT AAT ATC GGA GG\           94 °C 5 min (94 °C 30 s, 58 °C 30 s, 72 °C 30 s) × 35 and 72 °C 5 min       Rosato AE et al.[@bib0330]
                          CAT TAC ACT CTT GGC GGT TT                                                                                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Antibiotyping profile and virulence genes of the 20 *S. aureus* strains included in this study.

Table 2

  *S. aureus*   Resistance phenotypes                         Virulence genes                      
  ------------- --------------------------------------------- ----------------- ---- ---- ---- --- ---
  N--340        AMP/AZI/CPM/ERI/NEO                           \+                \+   \+   −    −   −
  N--341        AMP/NEO                                       \+                \+   \+   −    −   −
  N--345        SUT                                           \+                \+   \+   −    −   −
  N--346        EST                                           −                 \+   −    \+   −   −
  N--348        SUT                                           \+                \+   \+   −    −   −
  N--351        EST                                           \+                \+   \+   −    −   −
  N--352        AMP/CLO/SUT/TET                               \+                \+   −    \+   −   −
  N--353        ENO/ERI                                       −                 −    −    −    −   −
  N--354        AZI/CIP/CLO/MFX/NOV                           \+                \+   −    −    −   −
  N--359        NOV                                           \+                \+   −    −    −   −
  N--360        Susceptible                                   \+                \+   \+   −    −   −
  N--361        CIP/NOV                                       \+                \+   −    −    −   −
  N--363        Susceptible                                   \+                \+   −    −    −   −
  N--364        SUT                                           \+                −    −    −    −   −
  N--365        Susceptible                                   −                 \+   −    −    −   −
  N--366        Susceptible                                   −                 −    −    −    −   −
  N--367        CIP/EST/MFX/NOV                               \+                \+   −    −    −   −
  N--370        ENO/EST/SUT                                   \+                \+   −    −    −   −
  N--385        AMP/AZI/CIP/CLO/ENO/MFX/NOV/SUT               −                 \+   −    −    −   −
  N--386        AMO/AMP/AZI/CIP/CLO/ENO/EST/MFX/NEO/NOV/SUT   \+                \+   \+   −    −   −

AMO, amoxicillin; AMP, ampicillin; AZI, azithromycin; CIP, ciprofloxacin; CLO, chloramphenicol; CPM, cefepime; ENO, enrofloxacin; ERI, erythromycin; EST, streptomycin; MFX, moxifloxacin; NEO, neomycin; NOV, novobiocin; SUT, cotrimoxazole; TET, tetracycline. +, positive amplification; −, negative amplification.

###### 

Biofilm production, *agr* system classification and presence of the genes *icaA, icaD*, *bap*, *agr RNA III*, *blaZ* and *mecA* in S. *aureus* strains isolated from bovine mastitis.

Table 3

  *S. aureus*                                      Biofilm-producers   *icaA*   *icaD*   *bap*   *agr RNAIII*   Agr types   *blaZ*   *mecA*
  ------------------------------------------------ ------------------- -------- -------- ------- -------------- ----------- -------- --------
  N--348, N--352, N--353, N--359, N--361, N--367   Strong              \+       \+       −       \+             II          \+       −
  N--351                                           Strong              \+       \+       −       \+             NT          \+       −
  N--346                                           Strong              \+       \+       −       \+             NT          −        −
  N--341                                           Strong              \+       \+       \+      \+             NT          −        −
  N--340                                           Strong              −        \+       −       \+             NT          −        −
  N--370                                           Strong              \+       −        −       \+             II          \+       −
  N--360, N--363, N--364,N--365                    Moderate            \+       \+       −       \+             II          \+       −
  N--386                                           Moderate            −        \+       −       \+             II          −        −
  N--345                                           Moderate            \+       \+       −       \+             NT          −        −
  N--354                                           Weak                \+       \+       −       \+             NT          \+       −
  N--385                                           Weak                \+       \+       −       \+             NT          −        −
  N--366                                           Weak                −        \+       −       \+             II          \+       −

NT, not typable; +, positive; −, negative.
